Pure Global

“Vircell” VARICELLA-ZOSTER VIRCLIA IgM MONOTEST - Taiwan Registration 26b7cf027e9899a627a9db8255830301

Access comprehensive regulatory information for “Vircell” VARICELLA-ZOSTER VIRCLIA IgM MONOTEST in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 26b7cf027e9899a627a9db8255830301 and manufactured by VIRCELL, S.L. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
26b7cf027e9899a627a9db8255830301
Registration Details
Taiwan FDA Registration: 26b7cf027e9899a627a9db8255830301
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

“Vircell” VARICELLA-ZOSTER VIRCLIA IgM MONOTEST
TW: “凡賽爾”水痘帶狀疱疹病毒化學冷光免疫分析IgM試劑組
Risk Class 2
MD

Registration Details

26b7cf027e9899a627a9db8255830301

Ministry of Health Medical Device Import No. 032152

DHA05603215204

Company Information

Spain

Product Details

This product is an indirect chemiluminescent immunoassay (CLIA) reagent, combined with Thunderbolt Immunoassay Analyzer, to qualitatively detect IgM antibodies against varicella zoster virus in human plasma.

C Immunology and microbiology devices

C3900 Varicella zoster virus serum reagent

Imported from abroad

Dates and Status

Jan 25, 2019

Jan 25, 2024